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Abstract: 
 
 The identification of novel endogenous mediators of angiogenic/vasculogenic 
processes may provide for novel therapeutic targets to modulate blood vessel growth in 
disease states, such as cardiovascular disease or cancer.  Studies in our lab have shown 
that blood vessels in kidney have little endogenous regenerative capacity.   Kidney 
derived microvascular endothelial cells (KEC) were isolated from rat kidney or from 
transgenic mice bearing the temperature sensitive SV40 mutant (and subsequently grown 
at non-permissive temperature, 37oC).  Both rat and mouse KECs manifested 
significantly reduced growth rates when compared with several commonly used EC lines 
(rat pulmonary EC, HUVEC and human cord blood colony forming ECs).   In 2D 
matrigel assays, all commonly used ECs faithfully formed characteristic branching 
structures; while all KECs failed to form stabile branching structures.   Time-course 
analysis of branching activity demonstrated that KEC initially formed primitive 
branching nodes within 3 hours of culture, but these structures regressed such that no 
branched structures were observed between 6-12 hours.  Co-culture of KECs with any 
branching competent EC impaired branching dose dependently.   When co-cultured with 
ECFC, labeled KECs incorporated into primitive ECFC branches within the first 3 hours 
of plating.  However, when compared with ECFC branches, ECFC-KEC mixed branches 
showed a more rapid regression of the branched structures between 12-24 hrs.  
Interestingly, conditioned media from KEC did not affect branching of competent ECFC.  
Taken together, these data indicate that KEC have anti-angiogenic activity that may 
destabilize ECs during angiogenesis. The anti-angiogenic activity requires cell-cell 
contact, suggesting the possible presence of an angio-inhibitory molecule on the cell 
surface of KECs.   Current and future studies seek to generate additional KEC lines, and 
will determine if KEC cell fractions mediate the anti-angiogenic effect. In addition, we 
will seek to determine if KECs mitigate progression of angiogenic dependent tumor 
formation in vivo.   
 
 
